US FDA’s vagueness helps it win Supreme Court backing in Triton/Vapetasia case

Extreme vagueness has got the US Food and Drug Administration (FDA) off the hook in the latest major challenge on its handling of premarket tobacco product applications (PMTAs).

In a major, unanimous opinion, the US Supreme Court vacated and remanded the appealed Fifth Circuit Court decision in the case between the FDA and the vaping companies Wages and White Lion Investments – doing business as Triton Distribution and Vapetasia, respectively.

Read full article
I'm already a subscriber

Freddie Dawson

Senior contributing editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization